Has Kathleen Nemer, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,488 in general payments to Kathleen Nemer, MD across 59 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kathleen Nemer, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kathleen Nemer, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kathleen Nemer, MD

MOHS-Micrographic Surgery · Athens, OHNPI 1982047924

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.5% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,396 and has fallen 65.6% since, to $480 in 2025.

$3,488in general payments, 2019–2025

Across 59 payments — averaging $59.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$825
Journey Medical Corporation$280
Lilly USA, LLC$254
Galderma Laboratories, L.p.$245
Incyte Corporation$242
Regeneron Healthcare Solutions, Inc.$237
plus $1K from 16 others

What the payments were for

Food & beverage$3,40398%
Education$862%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	10	$825
Journey Medical Corporation	2	$280
Lilly USA, LLC	10	$254
Galderma Laboratories, L.p.	3	$245
Incyte Corporation	3	$242
Regeneron Healthcare Solutions, Inc.	8	$237
Arcutis Biotherapeutics, Inc.	2	$197
Pfizer	3	$192
Sanofi	2	$155
Kerecis Limited	2	$131
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$125
Amgen	1	$124
Almirall LLC	1	$119
Sun Pharmaceutical Industries Inc.	2	$104
Novartis	1	$86
UCB, Inc.	1	$38
Dermavant Sciences, Inc.	1	$34
Johnson & Johnson	2	$33
Biofrontera Inc.	1	$21
LEO Pharma Inc.	1	$19
Kyowa Kirin, Inc.	1	$16
Misonix Inc	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,488 in reported general payments places this provider in the 80th percentile of 35 mohs-micrographic surgery providers in Ohio.

See all mohs-micrographic surgery providers in Ohio →

Medicare billing

Part B allowed, 2024

$659,075

Medicare patients

511

Services billed

1,602

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cefadroxil	285	$1,737
Doxycycline Monohydrate	119	$1,654
Doxycycline Hyclate	13	$138
Mupirocin	20	$113
Ciprofloxacin Hcl	20	$112
Acetaminophen-CodeineAcetaminophen With Codeine	12	$47
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	11	$38
Amoxicillin	34	$36
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	11	$28
Tramadol Hcl	20	$27

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Athens

Jorge Garcia ZuazagaConcord Township$149K
Morgan HottWarren$16K
Jennifer PopovskyMedina$15K
Justin WoodhouseMayfield Heights$7K
Mihir ShahWestlake$5K
Allison MoosallyFairlawn$5K
Abdel Kader TalPerrysburg$3K
Patrick KillianWestlake$3K
Alison DurhamCanton$3K
Larisa RavitskiyNew Albany$3K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →